Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Liver Diseases

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 73 articles: HTML format Text format

Single Articles

March 2010
1. BERTOIA M , Albanes D, Mayne ST, Mannisto S, et al
   No association between fruit, vegetables, antioxidant nutrients and risk of renal cell carcinoma.
   Int J Cancer. 2010;126:1504-12.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CHO LY , Yang JJ, Ko KP, Park B, et al
   Co-infection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. ARLT VM , Zuo J, Trenz K, Roufosse CA, et al
   Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. KAWASAKI Y , Omori Y, Li Q, Nishikawa Y, et al
   Cytoplasmic accumulation of connexin32 expands cancer stem cell population in human HuH7 hepatoma cells by enhancing its self-renewal.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. RUGGIERI A , Barbati C, Malorni W
   Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. JIANG R , Xia Y, Li J, Deng L, et al
   High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.
   Int J Cancer. 2010;126:1263-74.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
7. BAEK JY , Morris SM, Campbell J, Fausto N, et al
   TGF-ss inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. JIANG W , Wang XW, Unger T, Forgues M, et al
   Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. NG KT , Lee TK, Cheng Q, Wo JY, et al
   Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1.
   Int J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. LEE NP , Tsang FH, Shek FH, Mao M, et al
    Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. MIYAKE Y , Iwasaki Y, Yamamoto K
    Meta-analysis: Reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis C.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. KELLER G , Geist B, Slotta-Huspenina J, Langer R, et al
    Novel multiple, monoallelic KRAS mutations at codon 12 and 13.
    Int J Cancer. 2009;125:2744-5.
    PubMed     Text format     Related articles   
    
    
    November 2009
13. RANCHAL I , Gonzalez R, Bello RI, Ferrin G, et al
    The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity.
    Int J Cancer. 2009;125:2270-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. FANG M , Zhao YP, Zhou FG, Lu LG, et al
    N-glycan based models improve diagnostic efficacies in HBV-related hepatocellular carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
15. ATORRASAGASTI C , Malvicini M, Aquino JB, Alaniz L, et al
    Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. GAILHOUSTE L , Ezan F, Bessard A, Fremin C, et al
    RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. ZITTERMANN SI , Capurro MI, Shi W, Filmus J, et al
    Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
18. MIZUKOSHI E , Nakamoto Y, Arai K, Yamashita T, et al
    Enhancement of tumor-specific T cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. LIM SC , Choi JE, Kang HS, Iy Han S, et al
    Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
20. ZHU Z , Hao X, Yan M, Yao M, et al
    Cancer stem/progenitor cells are highly enriched in CD133(+)CD44(+) population in hepatocellular carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. SEITZ SJ , Schleithoff ES, Koch A, Schuster A, et al
    Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. MEERANG M , Nair J, Sirankapracha P, Thephinlap C, et al
    Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers: comparison with levels in the lymphocytes of thalassemia patients.
    Int J Cancer. 2009;125:759-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
23. CUI XD , Lee MJ, Yu GR, Kim IH, et al
    EFNA1 ligand and its receptor EphA2: Potential biomarkers for hepatocellular carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. DAGOUASSAT M , Suffee N, Hlawaty H, Haddad O, et al
    Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. NAKAGAWA H , Maeda S, Yoshida H, Tateishi R, et al
    Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients; An analysis based on gender differences.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
26. ARAI E , Ushijima S, Gotoh M, Ojima H, et al
    Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. WANG Y , Ausman LM, Greenberg AS, Russell RM, et al
    Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. SUN J , Yan Y, Wang XT, Liu XW, et al
    PTD4-apoptin protein therapy inhibits tumor growth in vivo.
    Int J Cancer. 2009;124:2973-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. LINDBOHM ML , Sallmen M, Kyyronen P, Kauppinen T, et al
    Risk of liver cancer and exposure to organic solvents and gasoline vapors among Finnish workers.
    Int J Cancer. 2009;124:2954-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. KABASHIMA A , Higuchi H, Takaishi H, Matsuzaki Y, et al
    Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.
    Int J Cancer. 2009;124:2771-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. NAKAMURA Y , Kominami A, Tsujimoto Y, Nakayama Y, et al
    Actin and Vimentin proteins with N-terminal deletion detected in tumor-bearing rat livers induced by intraportal-vein injection of Ha-ras-transfected rat liver cells.
    Int J Cancer. 2009;124:2512-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
32. ZHOU J , Ding T, Pan W, Zhu LY, et al
    Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. TOIYAMA Y , Miki C, Inoue Y, Okugawa Y, et al
    Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. WU CH , Ho YS, Tsai CY, Wang YJ, et al
    In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter.
    Int J Cancer. 2009;124:2210-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
35. VAN DEN EYNDEN GG , Van Laere SJ, Van der Auwera I, Trinh XB, et al
    Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
36. ZHU X , Chen MS, Tian LW, Li DP, et al
    Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: Risk and prognosis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
37. IETA K , Tanaka F, Yokobori T, Kita Y, et al
    Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. CHEN CH , Changchien CS, Lee CM, Tung WC, et al
    A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. MCDONALD B , Spicer J, Giannais B, Fallavollita L, et al
    Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
40. MORIBE T , Iizuka N, Miura T, Kimura N, et al
    Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. KAPOOR S
    The therapeutic benefits of heme oxygenase (HO-1) inhibition in the management of systemic malignancies besides hepatocellular carcinomas.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
42. ZHANG CH , Xu GL, Jia WD, Ge YS, et al
    Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: A meta-analysis of randomized controlled trials.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
43. WONG VW , Yu J, Cheng AS, Wong GL, et al
    High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. LI M , Li H, Li C, Zhou S, et al
    Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. MARTINEZ-BALIBREA E , Martinez-Cardus A, Musulen E, Gines A, et al
    Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. CAO W , Sun B, Feitelson MA, Wu T, et al
    Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. FEDERICI C , Brambilla D, Lozupone F, Matarrese P, et al
    Pleiotropic function of ezrin in human metastatic melanomas.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
48. CHOI DS , Kim HJ, Yoon JH, Yoo SC, et al
    Endometrial cancer invasion depends on cancer-derived tumor necrosis factor-alpha and stromal derived hepatocyte growth factor.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. MIYATA R , Ueda M, Jinno H, Konno T, et al
    Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. MORISAWA T , Marusawa H, Ueda Y, Iwai A, et al
    Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression.
    Int J Cancer. 2008;123:2735-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KUROIWA-TRZMIELINA J , de Conti A, Scolastici C, Pereira D, et al
    Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: Efficacy of tributyrin, a butyric acid prodrug.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. D'AGOSTINI F , Balansky R, Steele VE, Ganchev G, et al
    Preneoplastic and neoplastic lesions in the lung, liver and urinary tract of mice exposed to environmental cigarette smoke and UV light since birth.
    Int J Cancer. 2008;123:2497-502.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
53. MARX-STOELTING P , Borowiak M, Knorpp T, Birchmeier C, et al
    Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. ILLEMANN M , Bird N, Majeed A, Laerum OD, et al
    Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. KURAHASHI N , Inoue M, Iwasaki M, Tanaka Y, et al
    Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. ERIN N , Wang N, Xin P, Bui V, et al
    Altered gene expression in breast cancer liver metastases.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. CALVISI DF , Pinna F, Pellegrino R, Sanna V, et al
    Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control.
    Int J Cancer. 2008;123:2057-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
58. LEHMAN EM , Wilson ML
    Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta-analysis.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. TUNG EK , Wong CM, Yau TO, Lee JM, et al
    HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. WANG L , Li H, Zhang Y, Santella RM, et al
    HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. BARREIROS AP , Sprinzl M, Rosset S, Hohler T, et al
    EGF and HGF levels are increased during active HBV infection and enhance survival signaling through extracellular matrix interactions in primary human hepatocytes.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. SCHWARTZ B , Algamas-Dimantov A, Hertz R, Nataf J, et al
    Inhibition of colorectal cancer by targeting hepatocyte nuclear factor-4alpha.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
63. KIM TM , Yim SH, Shin SH, Xu HD, et al
    Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SASS G , Leukel P, Schmitz V, Raskopf E, et al
    Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice.
    Int J Cancer. 2008;123:1269-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. WANG Y , Ausman LM, Greenberg AS, Russell RM, et al
    Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. TSUCHIYA M , Kono H, Matsuda M, Fujii H, et al
    Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. LIAO YJ , Liu SP, Lee CM, Yen CH, et al
    Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. RIENER MO , Wild PJ, Soll C, Knuth A, et al
    Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. WONG N , Yeo W, Wong WL, Wong NL, et al
    TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
70. LEUNG EY , Crozier JE, Talwar D, O'Reilly DS, et al
    Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. DING Y , Chen B, Wang S, Zhao L, et al
    Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. HASSAN MM , Spitz MR, Thomas MB, El-Deeb AS, et al
    Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case-control study.
    Int J Cancer. 2008;123:1883-1891.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
73. LI W , Xie L, He X, Li J, et al
    Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: